|
 
Audience
Trends in Molecular Medicine provides cutting edge authoritative
perspectives on the latest breakthroughs in the multidisciplinary field
of molecular medicine. Trends in Molecular Medicine keeps students and research
professionals up to date with key developments, and provides a forum for
discussion and debate among basic scientists and clinicians, with a view
to facilitating progress in translational research. The audience comprises
medical students, graduate students in the biomedical sciences, scientists
(academic and industrial) and clinicians with an interest in understanding
the molecular basis of disease and in using molecular biology to develop
innovative approaches for the prevention, diagnosis and treatment of disease.
 
Instructions to Authors
Trends in Molecular Medicine is divided into three sections: Update,
Opinion and Review. Articles are invited by the Editor, but proposals are
welcome, especially for the Opinion section. Prospective authors should
send a brief summary (up to 300 words), citing key references, to the Editor,
who will supply guidelines on manuscript preparation if the proposal is
accepted. The submission of completed manuscripts without prior consultation
with the Editor is strongly discouraged. Authors should note that all articles
are peer-reviewed and publication cannot be guaranteed.
Review and Opinion articles form the foundation of each monthly issue.
Review articles are invited from leading researchers and provide objective
overviews and insights on key recent developments in newly emerging or
rapidly progressing fields. Opinion articles present a personal, authoritative
viewpoint on a particular topic. They can cover timely controversial issues
or debates, provide a new framework for, or interpretation of, an old
problem or current issue, or speculate in depth on the implications of
recently published research. All articles are peer reviewed and edited
to ensure that they are timely, accurate, interesting and relevant to
the audience of Trends in Molecular Medicine. Every effort is made
to explain specialist terms and illustrate concepts and hypotheses.
The Update section includes topical features such as Letters and Research
Focus articles:
- Trends in Molecular Medicine welcomes correspondence. Letters
on any topic of interest may be submitted to the Editor (at tmm@elsevier.com).
The decision to publish rests with the Editor, and the author(s) of
any article discussed in a Letter will normally be invited to reply.
Letters may address topics raised in recent issues of the journal, or
other matters of general interest to biomedical scientists. Appropriate
topics include comments, questions and discussion on articles and topics
covered by Trends in Molecular Medicine, new Internet resources,
ethical and legal issues, regulatory issues, and business and financial
issues. Please note that previously unpublished data or criticisms of
work published elsewhere cannot be published.
- Research Focus articles alert readers to recent primary papers that
are important to biomedical researchers, are particularly innovative,
likely to have significant clinical impact, or are controversial.
 
Editorial Board
S. Agrawal, Cambridge, USA
K. Alitalo, Helsinki, Finland
H. Blau, Stanford, USA
T. Cox, Cambridge, UK
K. Culver, East Hanover, USA
K. Davies, Oxford, UK
I. Dunham, Hinxton, UK
F. Gage, La Jolla, USA
D. Gordon, Manchester, UK
W. Günzburg, Vienna, Austria
D. Gurwitz, Tel Aviv, Israel
M.A. Liu, Emeryville, USA
K. Matsushima, Tokyo, Japan
A. McMichael, Oxford, UK
A. Papavassiliou, Athens, Greece
W. Petri, Charlottesville, USA
D. Rader, Philadelphia, USA
C. Soto, Galveston, USA
T. Soussi, Paris, France
G.C. Tsokos, Silver Spring, USA
L.-C. Tsui, Toronto, Canada
J. Uitto, Philadelphia, USA
S. Waxman, New Haven, USA
 
Abstracting/Indexing
Biochemistry & Biophysics Citation Index
CAB Abstracts International
Chemical Abstracts
Current Contents (Life Science)
Index Veterinarius
Medline/MEDLARS Online
Nucleic Acids Abstracts
SciSearch/Science Citation Index Expanded
 
Bibliographic Information
Commenced publication 1995
Volume 14
2008, 12 issues
ISSN: 1471-4914
 
Statement on publishing ethics
The
Editor(s) and Publisher of this Journal believe that there are fundamental
principles underlying scholarly or professional publishing. While this
may not amount to a formal 'code of conduct', these fundamental principles
with respect to the authors' paper are that the paper should: i) be the
authors' own original work, which has not been previously published elsewhere,
ii) reflect the authors' own research and analysis and do so in a truthful
and complete manner, iii) properly credit the meaningful contributions
of co-authors and co-researchers, iv) not be submitted to more than one
journal for consideration, and v) be appropriately placed in the context
of prior and existing research. Of equal importance are ethical guidelines
dealing with research methods and research funding, including issues dealing
with informed consent, research subject privacy rights, conflicts of interest,
and sources of funding. While it may not be possible to draft a 'code'
that applies adequately to all instances and circumstances, we believe
it useful to outline our expectations of authors and procedures that the
Journal will employ in the event of questions concerning author conduct.
 
Conflict of Interest Policy
The
Publisher now requires authors to declare any conflicts of interest that
relate to papers accepted for publication in this Journal. A conflict
of interest may exist when an author or the author's institution has a
financial or other relationship with other people or organizations that
may inappropriately influence the author’s work. A conflict can be actual
or potential and full disclosure to the Journal is the safest course.
All submissions to the Journal must include disclosure of all relationships
that could be viewed as presenting a potential conflict of interest. The
Journal may use such information as a basis for editorial decisions and
may publish such disclosures if they are believed to be important to readers
in judging the manuscript. A decision may be made by the Journal not to
publish on the basis of the declared conflict. For more information, please
refer to:
http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest
 
Copyright statement
© 2008 Elsevier Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected
under copyright by Elsevier Ltd, and the following terms and conditions
apply to their use:
 
Photocopying
Single photocopies of single articles may be made for personal use as
allowed by national copyright laws. Permission of the publisher and payment
of a fee is required for all other photocopying, including multiple or
systematic copying, copying for advertising or promotional purposes, resale,
and all forms of document delivery. Special rates are available for educational
institutions that wish to make photocopies for non-profit educational
classroom use.
Elsevier Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk
|
|
You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.
In the USA, users
may clear permissions and make payments through the
Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923 USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744
and in the UK through
the
Copyright Licensing
Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London
UK W1P 0LP
Tel: +44 (0)
20 7631 5555
Fax: +44 (0)
20 7436 5500
Other countries may
have a local reprographic rights agency for payments.
 
Derivative Works
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for
internal circulation within their institutions. Permission of the publisher
is required for resale or distribution outside the institution.
Permission of the publisher is required for all other derivative works,
including compilations and translations.
 
Electronic Storage or Usage
Permission of the publisher is required to store or use electronically
any material contained in this journal, including any article or part
of an article. Contact the publisher at the address indicated. Except
as outlined above, no part of this publication may be reproduced, stored
in a retrieval system or transmitted in any form or by any means, electronic,
mechanical, photocopying, recording or otherwise, without prior written
permission of the publisher. Address permissions requests to: Elsevier
Science Rights & Permissions Department, at the mail, fax and e-mail addresses
noted above.
 
Notice
No responsibility is
assumed by the Publisher for any injury and/or damage to persons or property
as a matter of products liability, negligence or otherwise, or from any
use or operation of any methods, products, instructions or ideas contained
in the material herein. Because of rapid advances in the medical sciences,
in particular, independent verification of diagnoses and drug dosages
should be made.
Although all advertising material is expected to conform to ethical (medical)
standards, inclusion in this publication does not constitute a guarantee
or endorsement of the quality or value of such product or of the claims
made of it by its manufacturer.
|